Proteomics

Dataset Information

0

MARK2/MARK3 kinases are catalytic co-dependencies of YAP/TAZ in human cancer


ABSTRACT: Human cancer is often caused by dysfunctional developmental pathways, but such mechanisms do not always present clear opportunities for therapeutic intervention. This is exemplified by the Hippo tumor suppressor pathway, which is comprised of a kinase module that restrains the function of YAP/TAZ transcriptional coactivators; a pathway that becomes dysregulated in a wide array of human cancers. Hence, YAP/TAZ hyperactivation is a tumorigenic mechanism and a validated therapeutic target in oncology. In this study, we used a paralog co-targeting genetic screening strategy to identify the kinases MARK2/3 as co-dependencies of YAP/TAZ in diverse cancer contexts. We use biochemical and epistasis experiments to show that MARK2/3 phosphorylate and inhibit the activity of Hippo pathway components NF2, MST1/2, and MAP4Ks, which leads to indirect upstream control of LATS1/2 activity. In addition, MARK2/3 directly phosphorylate YAP/TAZ to shield these coactivators from LATS1/2-mediated inhibition. The net consequence of this multi-level regulation is that YAP/TAZ-dependent human cancers have an absolute requirement for MARK2/3 catalytic activity to sustain tumor cell proliferation and viability. To simulate therapeutic targeting of MARK2/3 in vivo, we adapted the EPIYA-repeat region of the CagA protein from H. pylori as a catalytic inhibitor of MARK2/3, which we show exerts potent anti-tumor activity via on-target mechanisms. Together, these findings reveal MARK2/3 as an obligate catalytic requirement for YAP/TAZ function in human cancer; kinase targets that may allow for novel pharmacology that restores Hippo-mediated tumor suppression.

INSTRUMENT(S): Orbitrap Fusion Lumos

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Paolo Cifani  

LAB HEAD: Paolo Cifani

PROVIDER: PXD044829 | Pride | 2024-07-25

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
220608_OK_CDC25C_MARK.raw Raw
220608_OK_CDC25C_negctrl.raw Raw
220608_OK_CDC25C_peptides.xlsx Xlsx
220608_OK_CDC25C_proteins.xlsx Xlsx
220608_OK_MST1_MARK.raw Raw
Items per page:
1 - 5 of 38

Similar Datasets

2024-07-25 | PXD054192 | Pride
2024-01-26 | PXD040448 | Pride
2019-11-13 | GSE117116 | GEO
2018-02-13 | GSE99040 | GEO
2019-02-19 | GSE120015 | GEO
2019-02-19 | GSE120014 | GEO
2019-02-19 | GSE119935 | GEO
2023-10-04 | GSE222962 | GEO
2023-10-04 | GSE222960 | GEO
2020-06-24 | GSE152369 | GEO